Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336453
Status:
COMPLETED
Last Update Posted:
2009-12-17
First Post:
2006-06-12
Brief Title:
Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics
Sponsor:
Protein Sciences Corporation
Organization:
Protein Sciences Corporation
Organization Data
Organization:
Protein Sciences Corporation
Class:
INDUSTRY
Study ID:
PSC02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Protein Sciences Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Manon Cox Chief Operating Officer
Old Organization:
Protein Sciences Corporation